Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Min Wah T"'
Autor:
Collinson F; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Royle KL; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Swain J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Ralph C; Leeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds, UK., Maraveyas A; Academic Oncology, Faculty of Health Sciences, Hull York Medical School, Queens Centre Oncology and Haematology, Hull, UK., Eisen T; Department of Oncology, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK., Nathan P; Department of Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Hertfordshire, UK., Jones R; School of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., Meads D; Academic Unit of Health Economics, University of Leeds, Leeds, UK., Min Wah T; Department of Diagnostic and Interventional Radiology, Leeds Teaching Hospitals Trust, Leeds, UK., Martin A; Academic Unit of Health Economics, University of Leeds, Leeds, UK., Bestall J; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Kelly-Morland C; Department of Cancer Imaging, King's College London, London, UK., Linsley C; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Oughton J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Chan K; Medical Oncology, Weston Park Cancer Hospital, Sheffield, UK., Theodoulou E; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK., Arias-Pinilla G; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK., Kwan A; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK., Daverede L; Department of Clinical Oncology, Austral University Hospital, Buenos Aires, Argentina., Handforth C; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK., Trainor S; St James's Institute of Oncology, St James's University Hospital, Leeds, UK., Salawu A; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK., McCabe C; Institute of Health Economics, University of Alberta, Edmonton, Canada., Goh V; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Buckley D; Faculty of Medicine and Health, School of Medicine, University of Leeds, Leeds, UK., Hewison J; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Gregory W; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Selby P; Leeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds, UK., Brown J; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Brown J; Division of Clinical Medicine, University of Sheffield, Weston Park Hospital, Sheffield, UK.
Publikováno v:
Health technology assessment (Winchester, England) [Health Technol Assess] 2024 Aug; Vol. 28 (45), pp. 1-171.
Autor:
Brown JE; Department of Oncology and Metabolism, University of Sheffield, Weston Park Hospital, Sheffield. Electronic address: j.e.brown@sheffield.ac.uk., Royle KL; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Gregory W; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Ralph C; Leeds Institute of Medical Research at St James's, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Maraveyas A; Queens Centre for Oncology and Haematology, Faculty of Health Sciences, Hull York Medical School, Hull, UK., Din O; Department of Clinical Oncology, Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Eisen T; Department of Oncology, University of Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Nathan P; Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Northwood, UK., Powles T; Barts Cancer Institute, Queen Mary University, London, UK., Griffiths R; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Jones R; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., Vasudev N; Leeds Institute of Medical Research at St James's, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Wheater M; University Hospital Southampton NHS Foundation Trust, Southampton, UK., Hamid A; Broomfield Hospital, Mid and South Essex NHS Foundation Trust, Chelmsford, UK., Waddell T; Christie NHS Foundation Trust, Manchester, UK., McMenemin R; Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Patel P; Academic Unit of Translational Medical Sciences, University of Nottingham, Nottingham, UK., Larkin J; Royal Marsden NHS Foundation Trust, London, UK., Faust G; Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK., Martin A; Academic Unit of Health Economics, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Swain J; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Bestall J; Leeds Institute of Health Sciences, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., McCabe C; Centre for Public Health, Queens University, Belfast, UK., Meads D; Academic Unit of Health Economics, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Goh V; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Min Wah T; Department of Radiology, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Brown J; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Hewison J; Leeds Institute of Health Sciences, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Selby P; Leeds Institute of Medical Research at St James's, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Collinson F; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 Mar; Vol. 24 (3), pp. 213-227. Date of Electronic Publication: 2023 Feb 13.
Autor:
Campana, Luca G.1 (AUTHOR) francesco.lancellotti@mft.nhs.uk, Daud, Adil2 (AUTHOR) adil.daud@ucsf.edu, Lancellotti, Francesco1 (AUTHOR), Arroyo, Julio P.3 (AUTHOR) jparroyo@vt.edu, Davalos, Rafael V.3,4 (AUTHOR) davalos@vt.edu, Di Prata, Claudia5 (AUTHOR) claudiadipratamd@gmail.com, Gehl, Julie6,7 (AUTHOR) kgeh@regionsjaelland.dk
Publikováno v:
Cancers. Jul2023, Vol. 15 Issue 13, p3340. 42p.
Publikováno v:
CardioVascular & Interventional Radiology; Nov2023 Suppl 4, Vol. 46, p431-1733, 1303p
Autor:
Janet E Brown, Kara-Louise Royle, Walter Gregory, Christy Ralph, Anthony Maraveyas, Omar Din, Timothy Eisen, Paul Nathan, Tom Powles, Richard Griffiths, Robert Jones, Naveen Vasudev, Matthew Wheater, Abdel Hamid, Tom Waddell, Rhona McMenemin, Poulam Patel, James Larkin, Guy Faust, Adam Martin, Jayne Swain, Janine Bestall, Christopher McCabe, David Meads, Vicky Goh, Tze Min Wah, Julia Brown, Jenny Hewison, Peter Selby, Fiona Collinson, Judith Carser, Gopalakrishnan Srinivasan, Fiona Thistlewaite, Ashraf Azzabi, Mark Beresford, David Farrugia, Marios Decatris, Carys Thomas, Joanna Gale, James McAleer, Alison Clayton, Ekaterini Boleti, Thomas Geldart, Santhanam Sundar, Jason Lester, Nachi Palaniappan, Mohan Hingorani, Khaliq Rehman, Mohammad Khan, Naveed Sarwar, Janine Graham, Alastair Thomson, Narayanan Srihari, Denise Sheehan, Rajaguru Srinivasan, Omar Khan, Andrew Stockdale Jane Worlding, Stergios Boussios, Nicholas Stuart, Carey MacDonald-Smith, Falalu Danwata, Duncan McLaren, Aravindhan Sundaramurthy, Anna Lydon, Sharon Beesley, Kathryn Lees, Mohini Varughese, Emma Gray, Angela Scott, Mark Baxter, Anna Mullard, Pasquale Innominato, Gaurav Kapur, Anil Kumar, Natalie Charnley, Caroline Manetta, Prabir Chakraborti, Prantik Das, Sarah Rudman, Henry Taylor, Christos Mikropoulos, Martin Highley, Dakshinamoorthy Muthukumar, Anjali Zarkar, Roy Vergis, Seshadri Sriprasad, Patryk Brulinski, Amanda Clarke, Richard Osbourne, Melanie Harvey, Renata Dega, Geoffrey Sparrow, Urmila Barthakur, Erica Beaumont, Agnieszka Michael, Emilio Porfiri, Faisal Azam, Ravi Kodavtiganti
Publikováno v:
STAR Investigators, Brown, J E, Royle, K-L, Gregory, W, Ralph, C, Maraveyas, A, Din, O, Eisen, T, Nathan, P, Powles, T, Griffiths, R, Jones, R, Vasudev, N, Wheater, M, Hamid, A, Waddell, T, McMenemin, R, Patel, P, Larkin, J, Faust, G, Martin, A, Swain, J, Bestall, J, McCabe, C, Meads, D, Goh, V, Min Wah, T, Brown, J, Hewison, J, Selby, P & Collinson, F 2023, ' Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial ', Lancet Oncology, vol. 24, no. 3, pp. 213-227 . https://doi.org/10.1016/S1470-2045(22)00793-8
Temporary drug treatment cessation might alleviate toxicity without substantially compromising efficacy in patients with cancer. We aimed to determine if a tyrosine kinase inhibitor drug-free interval strategy was non-inferior to a conventional conti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a633cdaf72543d0ca87f46d23005d79
https://doi.org/10.1016/s1470-2045(22)00793-8
https://doi.org/10.1016/s1470-2045(22)00793-8